<PubmedArticle>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">26798588</PMID>
<DateCompleted>
<Year>2016</Year>
<Month>01</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">2218-6751</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>4</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Translational lung cancer research</Title>
<ISOAbbreviation>Transl Lung Cancer Res</ISOAbbreviation>
</Journal>
<ArticleTitle>Lung cancer treatment outcomes in recipients of lung transplant.</ArticleTitle>
<Pagination>
<MedlinePgn>784-91</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3978/j.issn.2218-6751.2015.12.08</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lung transplant recipients develop lung cancer more commonly than the general population. The best treatment approach for these patients is unclear. The goal of this study is to evaluate treatment outcomes in this population.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We used the Cleveland Clinic lung transplant database to identify patients diagnosed with lung cancer at the time of or after lung transplant. Transplant and lung cancer-related data were retrospectively reviewed.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 847 patients underwent lung transplant between 2005 and 2013, 17 (2%) were diagnosed with lung cancer and included. Median age was 61 (range, 48-70) years. Majority were stage I/II (n=11), one had stage IIIA, five had stage IV. Non-small cell lung cancer (NSCLC) were more common than small cell lung cancer (SCLC) (n=15 vs. 2). Curative treatment was performed as lobectomy in native lung (n=1), and radiation in transplanted lung (n=2). Chemotherapy was given in 10 patients, primarily carboplatin-based doublets with docetaxel, pemetrexed, or etoposide. Six of these received palliative chemotherapy for either metastases at diagnosis (n=3) or recurrence after early stage disease (n=3). Except for one patient with complete response, all others had progressive disease following palliative chemotherapy. Overall, patients who received chemotherapy had a median survival of 7.5 months from the initiation of chemotherapy, but 30% developed grade 5 sepsis. Median survival for stage I-IIIA and stage IV were 23.2 and 2.5 months respectively.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Lung cancer in lung transplant recipients carries various clinical courses. Patients with metastatic disease have substantial toxicities from chemotherapy and poor survival. Early stage patients should be offered treatment with modified dosages to decrease the risk of severe toxicities.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Du</LastName>
<ForeName>Lingling</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>1 Division of Medical Oncology, Department of Internal Medicine, Washington University School of Medicine, Saint Louis, MO, USA ; 2 Department of Solid Tumor Biology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA ; 3 Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, USA ; 4 Division of Medical Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pennell</LastName>
<ForeName>Nathan A</ForeName>
<Initials>NA</Initials>
<AffiliationInfo>
<Affiliation>1 Division of Medical Oncology, Department of Internal Medicine, Washington University School of Medicine, Saint Louis, MO, USA ; 2 Department of Solid Tumor Biology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA ; 3 Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, USA ; 4 Division of Medical Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Elson</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>1 Division of Medical Oncology, Department of Internal Medicine, Washington University School of Medicine, Saint Louis, MO, USA ; 2 Department of Solid Tumor Biology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA ; 3 Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, USA ; 4 Division of Medical Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hashemi-Sadraei</LastName>
<ForeName>Nooshin</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>1 Division of Medical Oncology, Department of Internal Medicine, Washington University School of Medicine, Saint Louis, MO, USA ; 2 Department of Solid Tumor Biology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA ; 3 Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, USA ; 4 Division of Medical Oncology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>China</Country>
<MedlineTA>Transl Lung Cancer Res</MedlineTA>
<NlmUniqueID>101646875</NlmUniqueID>
<ISSNLinking>2218-6751</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Lung cancer</Keyword>
<Keyword MajorTopicYN="N">chemotherapy</Keyword>
<Keyword MajorTopicYN="N">lung transplant</Keyword>
<Keyword MajorTopicYN="N">outcome</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>1</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>1</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>1</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26798588</ArticleId>
<ArticleId IdType="doi">10.3978/j.issn.2218-6751.2015.12.08</ArticleId>
<ArticleId IdType="pii">tlcr-04-06-784</ArticleId>
<ArticleId IdType="pmc">PMC4700231</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Thorac Imaging. 2000 Jan;15(1):36-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10634661</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thorac Oncol. 2008 Dec;3(12):1404-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19057264</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Heart Lung Transplant. 2006 Nov;25(11):1297-301</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17097492</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Heart Lung Transplant. 2001 Oct;20(10):1044-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11595559</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lung Cancer. 2011 Nov;74(2):280-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21529983</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Radiology. 2002 Jul;224(1):131-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12091672</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thorac Cardiovasc Surg. 2002 Dec;124(6):1190-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12447186</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Heart Lung Transplant. 2012 Jun;31(6):585-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22425236</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Transplant Proc. 2004 Nov;36(9):2808-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15621155</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Transplant Proc. 1984 Apr;16(2):492-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6719551</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24399786</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>